{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:41:06Z","timestamp":1791423666635,"version":"4.3.3"},"reference-count":316,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Medicine Open"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ajmo.2024.100068","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T14:10:57Z","timestamp":1707919857000},"page":"100068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6543-7727","authenticated-orcid":false,"given":"Pawe\u0142","family":"Koz\u0142owski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Leszczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Ciepiela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajmo.2024.100068_bib0001","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbrc.2020.10.087","article-title":"History of the COVID-19 pandemic: origin, explosion, worldwide spreading","volume":"538","author":"Platto","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajmo.2024.100068_bib0002","unstructured":"Naming the coronavirus disease (COVID-19) and the virus that causes it. https:\/\/www.who.int\/Emergencies\/Diseases\/Novel-Coronavirus-2019\/Technical-Guidance\/Naming-the-Coronavirus-Disease-(Covid-2019)-and-the-Virus-That-Causes-It. Retreived Aug 18, 2023."},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0003","first-page":"157","article-title":"WHO declares COVID-19 a pandemic","volume":"91","author":"Cucinotta","year":"2020","journal-title":"Acta Bio-Medica Atenei Parm"},{"key":"10.1016\/j.ajmo.2024.100068_bib0004","series-title":"World Health Statistics 2023: Monitoring Health For the SDGs, Sustainable Development Goals","year":"2023"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0005","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0006","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jamacardio.2020.1286","article-title":"Potential effects of coronaviruses on the cardiovascular system: a review","volume":"5","author":"Madjid","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.ajmo.2024.100068_bib0007","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.dsx.2020.03.013","article-title":"Cardiovascular disease and COVID-19","volume":"14","author":"Bansal","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0008","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11883-021-00935-2","article-title":"COVID and cardiovascular disease: what we know in 2021","volume":"23","author":"Chilazi","year":"2021","journal-title":"Curr Atheroscler Rep"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0009","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/07853890.2020.1790643","article-title":"Renal complications in COVID-19: a systematic review and meta-analysis","volume":"52","author":"Kunutsor","year":"2020","journal-title":"Ann Med"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0010","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.kint.2020.03.001","article-title":"The novel coronavirus 2019 epidemic and kidneys","volume":"97","author":"Naicker","year":"2020","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0011","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1038\/s41467-021-22781-1","article-title":"Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection","volume":"12","author":"Diao","year":"2021","journal-title":"Nature communications"},{"key":"10.1016\/j.ajmo.2024.100068_bib0012","first-page":"1","article-title":"Caution on kidney dysfunctions of COVID-19 patients","author":"Li","year":"2020","journal-title":"medRxiv"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0013","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S2468-1253(20)30126-6","article-title":"Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis","volume":"5","author":"Mao","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.ajmo.2024.100068_bib0014","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/gutjnl-2020-321013","article-title":"Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection","volume":"69","author":"Lin","year":"2020","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.ajmo.2024.100068_bib0015","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1053\/j.gastro.2020.02.055","article-title":"Evidence for gastrointestinal infection of SARS-CoV-2","volume":"158","author":"Xiao","year":"2020","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.ajmo.2024.100068_bib0016","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1053\/j.gastro.2020.02.054","article-title":"COVID-19: gastrointestinal manifestations and potential fecal\u2013oral transmission","volume":"158","author":"Gu","year":"2020","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.ajmo.2024.100068_bib0017","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1080\/00207454.2020.1853724","article-title":"Nervous system involvement in SARS-coronavirus infection: a review on lessons learned from the previous outbreaks, ongoing pandemic and what to expect in the future","volume":"132","author":"Bhatti","year":"2022","journal-title":"Int J Neurosci"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0018","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12038-021-00232-9","article-title":"Central nervous system as a target of novel coronavirus infections: potential routes of entry and pathogenic mechanisms","volume":"46","author":"Sharma","year":"2021","journal-title":"J Biosci"},{"issue":"11","key":"10.1016\/j.ajmo.2024.100068_bib0019","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1007\/s12031-020-01767-6","article-title":"Evidence of coronavirus (CoV) pathogenesis and emerging pathogen SARS-CoV-2 in the nervous system: a review on neurological impairments and manifestations","volume":"71","author":"Jha","year":"2021","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.ajmo.2024.100068_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-021-01102-5","article-title":"Peripheral nervous system manifestations associated with COVID-19","volume":"21","author":"Andalib","year":"2021","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"3","key":"10.1016\/j.ajmo.2024.100068_bib0021","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/bjd.19264","article-title":"Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue","volume":"183","author":"Marzano","year":"2020","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0022","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jaad.2020.05.059","article-title":"Cutaneous manifestations of COVID-19: a preliminary review","volume":"83","author":"Jia","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0023","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11882-020-00986-6","article-title":"Cutaneous manifestations related to COVID 19 immune dysregulation in the pediatric age group","volume":"21","author":"Larenas-Linnemann","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.ajmo.2024.100068_bib0024","unstructured":"What happens to people who get COVID-19? https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/coronavirus-disease-covid-19. Retreived Aug 18, 2023."},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jiph.2021.10.021","article-title":"Innovations and development of Covid-19 vaccines: a patent review","volume":"15","author":"Alshrari","year":"2022","journal-title":"J Infect Public Health"},{"issue":"24","key":"10.1016\/j.ajmo.2024.100068_bib0026","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154886","article-title":"The intersection of COVID-19 and autoimmunity","volume":"131","author":"Knight","year":"2021","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0027","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jmv.27292","article-title":"Autoimmune complications of COVID-19","volume":"94","author":"Yazdanpanah","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.ajmo.2024.100068_bib0028","doi-asserted-by":"crossref","first-page":"m3026","DOI":"10.1136\/bmj.m3026","article-title":"Management of post-acute covid-19 in primary care","volume":"370","author":"Greenhalgh","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ajmo.2024.100068_bib0029","first-page":"372:n136","article-title":"Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline","author":"Shah","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0030","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"A clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"22","author":"Soriano","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajmo.2024.100068_bib0031","doi-asserted-by":"crossref","unstructured":"Garg P., Arora U., Kumar A., et al. The \u201cpost-COVID\u201d syndrome: how deep is the damage? 2020;93(2):673\u2013674. 10.1002\/jmv.26465","DOI":"10.1002\/jmv.26465"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0032","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41467-020-20568-4","article-title":"Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)","volume":"12","author":"van Kampen","year":"2021","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0033","doi-asserted-by":"crossref","first-page":"576","DOI":"10.7326\/M20-5661","article-title":"Sixty-day outcomes among patients hospitalized with COVID-19","volume":"174","author":"Chopra","year":"2020","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0034","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cmi.2020.09.052","article-title":"Follow-up of adults with noncritical COVID-19 two months after symptom onset","volume":"27","author":"Carvalho-Schneider","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0035","doi-asserted-by":"crossref","first-page":"723","DOI":"10.7326\/M20-5926","article-title":"COVID-19 symptoms: longitudinal evolution and persistence in outpatient settings","volume":"174","author":"Nehme","year":"2020","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.ajmo.2024.100068_bib0036","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2020.12603","article-title":"Persistent symptoms in patients after acute COVID-19","volume":"324","author":"Carf\u00ec","year":"2020","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.ajmo.2024.100068_bib0037","doi-asserted-by":"crossref","first-page":"713","DOI":"10.15585\/mmwr.mm7121e1","article-title":"Post\u2013COVID conditions among adult COVID-19 survivors aged 18\u201364 and \u226565 years \u2014 United States, March 2020\u2013November 2021","volume":"71","author":"Bull-Otterson","year":"2022","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajmo.2024.100068_bib0038","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbi.2021.12.020","article-title":"Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis","volume":"101","author":"Ceban","year":"2022","journal-title":"Brain Behav Immun"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0039","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/s41591-022-01840-0","article-title":"Long COVID after breakthrough SARS-CoV-2 infection","volume":"28","author":"Al-Aly","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ajmo.2024.100068_bib0040","article-title":"Risk of long COVID in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: community-based, matched cohort study","author":"Ayoubkhani","year":"2022","journal-title":"medRxiv"},{"issue":"30","key":"10.1016\/j.ajmo.2024.100068_bib0041","doi-asserted-by":"crossref","first-page":"993","DOI":"10.15585\/mmwr.mm6930e1","article-title":"Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020","volume":"69","author":"Tenforde","year":"2020","journal-title":"Morb Mortal Wkly Rep"},{"issue":"17","key":"10.1016\/j.ajmo.2024.100068_bib0042","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.12998\/wjcc.v8.i17.3621","article-title":"Autoimmunity as the comet tail of COVID-19 pandemic","volume":"8","author":"Talotta","year":"2020","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.ajmo.2024.100068_bib0043","doi-asserted-by":"crossref","unstructured":"Groff D, Sun A, Ssentongo AE, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. 2021;4(10):e2128568. doi:10.1001\/jamanetworkopen.2021.28568.","DOI":"10.1001\/jamanetworkopen.2021.28568"},{"issue":"8","key":"10.1016\/j.ajmo.2024.100068_bib0044","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/biomedicines9080900","article-title":"Long-term impact of COVID-19: a systematic review of the literature and meta-analysis","volume":"9","author":"Sanchez-Ramirez","year":"2021","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0045","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.ajmo.2024.100068_bib0046","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-005427","article-title":"Characterising long COVID: a living systematic review","volume":"6","author":"Michelen","year":"2021","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.ajmo.2024.100068_bib0047","doi-asserted-by":"crossref","unstructured":"Lopez-Leon S., Wegman-Ostrosky T., Perelman C., et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. 2021;11(1):16144\u201316144. 10.21203\/rs.3.rs-266574\/v1","DOI":"10.1038\/s41598-021-95565-8"},{"key":"10.1016\/j.ajmo.2024.100068_bib0048","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.2147\/IJGM.S316708","article-title":"The conundrum of \u201cLong-COVID-19\u201d: a narrative review","volume":"14","author":"Garg","year":"2021","journal-title":"Int J Gen Med"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0049","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/fampra\/cmab076","article-title":"Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review","volume":"39","author":"van Kessel","year":"2022","journal-title":"Fam Pract"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0050","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41591-021-01292-y","article-title":"Attributes and predictors of long COVID","volume":"27","author":"Sudre","year":"2021","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.ajmo.2024.100068_bib0051","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0052","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02245-2021","article-title":"Long COVID: to investigate immunological mechanisms and sex\/gender related aspects as fundamental steps for a tailored therapy","volume":"52","author":"Ortona","year":"2022","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.ajmo.2024.100068_bib0053","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.7150\/ijbs.75056","article-title":"Long COVID and its management","volume":"18","author":"Koc","year":"2022","journal-title":"Int J Biol Sci"},{"issue":"3","key":"10.1016\/j.ajmo.2024.100068_bib0054","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.dsx.2021.04.007","article-title":"Long COVID: an overview","volume":"15","author":"Raveendran","year":"2021","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0055","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"issue":"18","key":"10.1016\/j.ajmo.2024.100068_bib0056","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.3390\/jcm10184143","article-title":"Association between long COVID and overweight\/obesity","volume":"10","author":"Vimercati","year":"2021","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.ajmo.2024.100068_bib0057","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1111\/dom.14454","article-title":"Association of obesity with postacute sequelae of COVID-19","volume":"23","author":"Aminian","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"7848","key":"10.1016\/j.ajmo.2024.100068_bib0058","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-020-03065-y","article-title":"Genetic mechanisms of critical illness in COVID-19","volume":"591","author":"Pairo-Castineira","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ajmo.2024.100068_bib0059","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.3201\/eid2608.201097","article-title":"Prolonged persistence of SARS-CoV-2 RNA in body fluids","volume":"26","author":"Sun","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.ajmo.2024.100068_bib0060","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/infdis\/jiab120","article-title":"The association between antibody response to severe acute respiratory syndrome coronavirus 2 infection and post-COVID-19 syndrome in healthcare workers","volume":"223","author":"Pereira","year":"2021","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.ajmo.2024.100068_bib0061","first-page":"1267","article-title":"Uncertainty around the long-term implications of COVID-19","volume":"10","author":"Desforges","year":"2021","journal-title":"Pathogenetics"},{"key":"10.1016\/j.ajmo.2024.100068_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103230","article-title":"SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses","volume":"64","author":"Vibholm","year":"2021","journal-title":"EBioMedicine"},{"issue":"6585","key":"10.1016\/j.ajmo.2024.100068_bib0063","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1126\/science.abm8108","article-title":"The immunology and immunopathology of COVID-19","volume":"375","author":"Merad","year":"2022","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0064","doi-asserted-by":"crossref","first-page":"10902","DOI":"10.1038\/s41598-021-90351-y","article-title":"Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients","volume":"11","author":"Chen","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajmo.2024.100068_bib0065","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijid.2020.12.051","article-title":"EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count","volume":"104","author":"Paolucci","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ajmo.2024.100068_bib0066","doi-asserted-by":"crossref","unstructured":"Simonnet A., Engelmann I., Moreau A.S., et al. High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically-ill patients with Covid-19. 2021;51(3):296\u2013299. 10.1016\/j.idnow.2021.01.005","DOI":"10.1016\/j.idnow.2021.01.005"},{"key":"10.1016\/j.ajmo.2024.100068_bib0067","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.aivir.2018.01.001","article-title":"Hosts and sources of endemic human coronaviruses","volume":"100","author":"Corman","year":"2018","journal-title":"Adv Virus Res"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0068","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12931-020-01479-w","article-title":"From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses","volume":"21","author":"Zhu","year":"2020","journal-title":"Respir Res"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0069","first-page":"98","article-title":"Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019","volume":"6","author":"Liu","year":"2020","journal-title":"Chronic Dis Transl Med"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0070","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.ajmo.2024.100068_bib0071","article-title":"Distribution of ACE2, CD147, cyclophilins, CD26 and other SARS-CoV-2 associated molecules in human tissues and immune cells in health and disease","author":"Radzikowska","year":"202075112829","journal-title":"bioRxiv"},{"issue":"6","key":"10.1016\/j.ajmo.2024.100068_bib0072","doi-asserted-by":"crossref","first-page":"e01815","DOI":"10.1128\/JVI.01815-18","article-title":"TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection","volume":"93","author":"Iwata-Yoshikawa","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.ajmo.2024.100068_bib0073","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.virol.2017.11.012","article-title":"Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry","volume":"517","author":"Shirato","year":"2017","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0074","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.ajmo.2024.100068_bib0075","doi-asserted-by":"crossref","first-page":"859","DOI":"10.20344\/amp.14612","article-title":"Post-COVID-19 syndrome (PC19S): chronic reactive endotheliitis and disseminated vascular disease","volume":"33","author":"Castro","year":"2020","journal-title":"Acta M\u00e9dica Port"},{"issue":"6","key":"10.1016\/j.ajmo.2024.100068_bib0076","doi-asserted-by":"crossref","first-page":"e13859","DOI":"10.1111\/dth.13859","article-title":"Unraveling the mystery of Covid-19 Cytokine storm: from skin to organ systems","volume":"33","author":"Garg","year":"2020","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0077","first-page":"135","article-title":"Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses","volume":"526","author":"Qi","year":"2020","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0078","first-page":"681","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"ArXiv Cell Behav"},{"key":"10.1016\/j.ajmo.2024.100068_bib0079","unstructured":"Ziegler C.G.K., Allon S.J., Nyquist S.J., et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. 2020;181(5):1016. 10.2139\/ssrn.3555145"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0080","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41422-020-0327-4","article-title":"COVID-19: towards understanding of pathogenesis","volume":"30","author":"Cao","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.ajmo.2024.100068_bib0081","doi-asserted-by":"crossref","unstructured":"Ashary N., Bhide A., Chakraborty P., et al. Single-cell RNA-seq identifies cell subsets in human placenta that highly expresses factors driving pathogenesis of SARS-CoV-2. 2020;8:783. 10.20944\/preprints202005.0195.v1","DOI":"10.3389\/fcell.2020.00783"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0082","first-page":"1","article-title":"SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19","volume":"13","author":"Zhang","year":"2020","journal-title":"J Hematol OncolJ Hematol Oncol"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0083","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/JVI.02202-13","article-title":"TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein","volume":"88","author":"Heurich","year":"2014","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.ajmo.2024.100068_bib0084","doi-asserted-by":"crossref","first-page":"6150","DOI":"10.1128\/JVI.03372-12","article-title":"TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium","volume":"87","author":"Bertram","year":"2013","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.ajmo.2024.100068_bib0085","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1128\/JVI.00128-13","article-title":"The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies","volume":"87","author":"Gierer","year":"2013","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0086","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/s41467-020-16048-4","article-title":"Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig","volume":"11","author":"Lei","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0087","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0088","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.immuni.2011.05.003","article-title":"Immune signaling by RIG-I-like receptors","volume":"34","author":"Loo","year":"2011","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0089","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0090","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3390\/v4050901","article-title":"Protective role of toll-like receptor 3-induced type I interferon in murine coronavirus infection of macrophages","volume":"4","author":"Mazaleuskaya","year":"2012","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0091","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-immunol-042718-041356","article-title":"Double-stranded RNA sensors and modulators in innate immunity","volume":"37","author":"Hur","year":"2019","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0092","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008737","article-title":"Interplay between SARS-CoV-2 and the type I interferon response","volume":"16","author":"Ribero","year":"2020","journal-title":"PLOS Pathog"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0093","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.ajmo.2024.100068_bib0094","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.3390\/v4112598","article-title":"dsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection","volume":"4","author":"Dabo","year":"2012","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0095","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.ajmo.2024.100068_bib0096","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1618310114","article-title":"Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages","volume":"114","author":"Deng","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.ajmo.2024.100068_bib0097","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1073\/pnas.0808790106","article-title":"Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase","volume":"106","author":"Chen","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.ajmo.2024.100068_bib0098","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1128\/JVI.02220-08","article-title":"Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-\u03baB signaling","volume":"83","author":"Frieman","year":"2009","journal-title":"J Virol"},{"issue":"34","key":"10.1016\/j.ajmo.2024.100068_bib0099","doi-asserted-by":"crossref","first-page":"12885","DOI":"10.1073\/pnas.0603144103","article-title":"Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation","volume":"103","author":"Kamitani","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.ajmo.2024.100068_bib0100","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.4049\/jimmunol.1303196","article-title":"SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS\/TRAF3\/TRAF6 signalosome","volume":"193","author":"Shi","year":"2014","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0101","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/JVI.01782-06","article-title":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists","volume":"81","author":"Kopecky-Bromberg","year":"2007","journal-title":"J Virol"},{"issue":"18","key":"10.1016\/j.ajmo.2024.100068_bib0102","doi-asserted-by":"crossref","first-page":"9812","DOI":"10.1128\/JVI.01012-07","article-title":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum\/Golgi membrane","volume":"81","author":"Frieman","year":"2007","journal-title":"J Virol"},{"issue":"16","key":"10.1016\/j.ajmo.2024.100068_bib0103","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1016\/j.molimm.2010.06.014","article-title":"SARS spike protein induces phenotypic conversion of human B cells to macrophage-like cells","volume":"47","author":"Chiang","year":"2010","journal-title":"Mol Immunol"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0104","doi-asserted-by":"crossref","first-page":"a016303","DOI":"10.1101\/cshperspect.a016303","article-title":"The Chemokine System in innate immunity","volume":"7","author":"Sokol","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6504","key":"10.1016\/j.ajmo.2024.100068_bib0105","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ajmo.2024.100068_bib0106","article-title":"The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes","author":"Feng","year":"2020","journal-title":"medRxiv"},{"issue":"6","key":"10.1016\/j.ajmo.2024.100068_bib0107","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: current state of the science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0108","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cell.2021.02.029","article-title":"COVID-19 and the human innate immune system","volume":"184","author":"Schultze","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ajmo.2024.100068_bib0109","doi-asserted-by":"crossref","unstructured":"Costela-Ruiz V.J., Illescas-Montes R., Puerta-Puerta J.M., et al. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. 2020;54:62\u201375. 10.1016\/j.cytogfr.2020.06.001","DOI":"10.1016\/j.cytogfr.2020.06.001"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0110","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin Immunopathol"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0111","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jmv.20255","article-title":"An interferon-\u03b3-related cytokine storm in SARS patients","volume":"75","author":"Huang","year":"2005","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.ajmo.2024.100068_bib0112","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12250-020-00207-4","article-title":"Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools","volume":"35","author":"Fu","year":"2020","journal-title":"Virol Sin"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0113","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1172\/JCI137647","article-title":"SARS-CoV-2: a storm is raging","volume":"130","author":"Pedersen","year":"2020","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.ajmo.2024.100068_bib0114","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/nsr\/nwaa041","article-title":"Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients","volume":"7","author":"Zhou","year":"2020","journal-title":"Natl Sci Rev"},{"key":"10.1016\/j.ajmo.2024.100068_bib0115","article-title":"COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome","author":"Zhang","year":"2020","journal-title":"medRxiv"},{"issue":"6","key":"10.1016\/j.ajmo.2024.100068_bib0116","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0117","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.immuni.2018.10.005","article-title":"Developmental and functional heterogeneity of monocytes","volume":"49","author":"Guilliams","year":"2018","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0118","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.cell.2013.03.010","article-title":"Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal","volume":"153","author":"Carlin","year":"2013","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.ajmo.2024.100068_bib0119","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/CIRCRESAHA.117.310739","article-title":"Endothelial protective monocyte patrolling in large arteries intensified by western diet and atherosclerosis","volume":"120","author":"Quintar","year":"2017","journal-title":"Circ Res"},{"issue":"5838","key":"10.1016\/j.ajmo.2024.100068_bib0120","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1126\/science.1142883","article-title":"Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior","volume":"317","author":"Auffray","year":"2007","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ajmo.2024.100068_bib0121","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.immuni.2010.08.012","article-title":"Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors","volume":"33","author":"Cros","year":"2010","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0122","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.20.2.026005","article-title":"Intravital live cell triggered imaging system reveals monocyte patrolling and macrophage migration in atherosclerotic arteries","volume":"20","author":"McArdle","year":"2015","journal-title":"J Biomed Opt"},{"issue":"11","key":"10.1016\/j.ajmo.2024.100068_bib0123","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1161\/ATVBAHA.117.309123","article-title":"Scavenger receptor CD36 directs nonclassical monocyte patrolling along the endothelium during early atherogenesis","volume":"37","author":"Marcovecchio","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0124","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI28549","article-title":"Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques","volume":"117","author":"Tacke","year":"2007","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrcardio.2009.228","article-title":"Monocytes in atherosclerosis: subsets and functions","volume":"7","author":"Woollard","year":"2010","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0126","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.crvasa.2015.08.002","article-title":"Monocyte adhesion to the endothelium is an initial stage of atherosclerosis development","volume":"58","author":"\u010cejkov\u00e1","year":"2016","journal-title":"Cor Vasa"},{"issue":"3","key":"10.1016\/j.ajmo.2024.100068_bib0127","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/CIRCRESAHA.111.253377","article-title":"NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis","volume":"110","author":"Hanna","year":"2012","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0128","doi-asserted-by":"crossref","first-page":"e87313","DOI":"10.1371\/journal.pone.0087313","article-title":"Nur77 decreases atherosclerosis progression in apoE\u2212\/\u2212 mice fed a high-fat\/high-cholesterol diet","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS One"},{"issue":"7985","key":"10.1016\/j.ajmo.2024.100068_bib0129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","article-title":"Distinguishing features of Long COVID identified through immune profiling","volume":"623","author":"Klein","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ajmo.2024.100068_bib0130","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1194\/jlr.M034157","article-title":"Bone marrow NR4A expression is not a dominant factor in the development of atherosclerosis or macrophage polarization in mice","volume":"54","author":"Chao","year":"2013","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0131","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1210\/me.2005-0331","article-title":"Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77","volume":"20","author":"Pei","year":"2006","journal-title":"Mol Endocrinol"},{"issue":"12","key":"10.1016\/j.ajmo.2024.100068_bib0132","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/ki.2008.500","article-title":"The chemokine receptors CCR2 and CX3CR1 mediate monocyte\/macrophage trafficking in kidney ischemia\u2013reperfusion injury","volume":"74","author":"Li","year":"2008","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0133","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1681\/ASN.2014020195","article-title":"Vascular-resident CD169-positive monocytes and macrophages control neutrophil accumulation in the kidney with ischemia-reperfusion injury","volume":"26","author":"Karasawa","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.ajmo.2024.100068_bib0134","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1084\/jem.20070885","article-title":"The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions","volume":"204","author":"Nahrendorf","year":"2007","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.ajmo.2024.100068_bib0135","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1161\/CIRCRESAHA.114.303204","article-title":"Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium","volume":"114","author":"Hilgendorf","year":"2014","journal-title":"Circ Res"},{"issue":"35","key":"10.1016\/j.ajmo.2024.100068_bib0136","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1606253113","article-title":"Patrolling monocytes promote intravascular neutrophil activation and glomerular injury in the acutely inflamed glomerulus","volume":"113","author":"Finsterbusch","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajmo.2024.100068_bib0137","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3389\/fimmu.2016.00512","article-title":"CD16+ monocyte subset was enriched and functionally exacerbated in driving T-cell activation and B-cell response in systemic lupus erythematosus","volume":"7","author":"Zhu","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajmo.2024.100068_bib0138","article-title":"Infiltrating CD16+ are associated with a reduction in peripheral CD14+CD16++ monocytes and severe forms of lupus nephritis","volume":"2016","author":"Garc\u00eda","year":"2016","journal-title":"Autoimmune Dis"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0139","doi-asserted-by":"crossref","first-page":"13886","DOI":"10.1038\/srep13886","article-title":"Non-classical monocytes display inflammatory features: validation in sepsis and systemic lupus erythematous","volume":"5","author":"Mukherjee","year":"2015","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0140","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.celrep.2014.09.032","article-title":"Nonclassical Ly6C\u2212 monocytes drive the development of inflammatory arthritis in mice","volume":"9","author":"Misharin","year":"2014","journal-title":"Cell Rep"},{"issue":"10","key":"10.1016\/j.ajmo.2024.100068_bib0141","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/annrheumdis-2018-213250","article-title":"Non-classical monocytes as mediators of tissue destruction in arthritis","volume":"77","author":"Puchner","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0142","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13075-015-0901-1","article-title":"Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists","volume":"18","author":"Lacerte","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0143","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.4049\/jimmunol.1501960","article-title":"Pivotal role for CD16+ monocytes in immune surveillance of the central nervous system","volume":"196","author":"Waschbisch","year":"2016","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0144","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/imcb.1025","article-title":"Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis","volume":"96","author":"Gjelstrup","year":"2018","journal-title":"Immunol Cell Biol"},{"issue":"36","key":"10.1016\/j.ajmo.2024.100068_bib0145","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1126\/sciimmunol.aar3054","article-title":"PD-L1 expression on nonclassical monocytes reveals their origin and immunoregulatory function","volume":"4","author":"Bianchini","year":"2019","journal-title":"Sci Immunol"},{"issue":"8","key":"10.1016\/j.ajmo.2024.100068_bib0146","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/cid\/ciaa449","article-title":"Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019","volume":"71","author":"Chen","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajmo.2024.100068_bib0147","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm; what we know so far","volume":"11","author":"Ragab","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0148","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"issue":"10223","key":"10.1016\/j.ajmo.2024.100068_bib0149","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0150","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0151","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/jmv.25770","article-title":"Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19","volume":"92","author":"Gao","year":"2020","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.ajmo.2024.100068_bib0152","first-page":"203","article-title":"Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia","volume":"43","author":"Chen","year":"2020","journal-title":"Chin J Tuberc Respir Dis"},{"issue":"34","key":"10.1016\/j.ajmo.2024.100068_bib0153","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1073\/pnas.2024358118","article-title":"Redox imbalance links COVID-19 and myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"118","author":"Paul","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0154","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41375-020-0887-9","article-title":"SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine \u201cstorm\u201d and risk factor for damage of hematopoietic stem cells","volume":"34","author":"Ratajczak","year":"2020","journal-title":"Leukemia"},{"issue":"7329","key":"10.1016\/j.ajmo.2024.100068_bib0155","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0156","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12015-020-10010-z","article-title":"SARS-CoV-2 entry receptor ACE2 is expressed on very small CD45 - precursors of hematopoietic and endothelial cells and in response to virus spike protein activates the Nlrp3 inflammasome","volume":"17","author":"Ratajczak","year":"2021","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0157","doi-asserted-by":"crossref","first-page":"e00911","DOI":"10.1002\/prp2.911","article-title":"\u201cLONG COVID\u201d: a hypothesis for understanding the biological basis and pharmacological treatment strategy","volume":"10","author":"Jarrott","year":"2022","journal-title":"Pharmacol Res Perspect"},{"issue":"7914","key":"10.1016\/j.ajmo.2024.100068_bib0158","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-022-04802-1","article-title":"Inflammasome activation in infected macrophages drives COVID-19 pathology","volume":"606","author":"Sefik","year":"2022","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0159","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"13","key":"10.1016\/j.ajmo.2024.100068_bib0160","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajmo.2024.100068_bib0161","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.647824","article-title":"Macrophages and dendritic cells are not the major source of pro-inflammatory cytokines upon SARS-CoV-2 infection","volume":"12","author":"Niles","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0162","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/infdis\/jiaa356","article-title":"Attenuated interferon and proinflammatory response in SARS-CoV-2-infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation","volume":"222","author":"Yang","year":"2020","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0163","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41232-020-00146-3","article-title":"How COVID-19 induces cytokine storm with high mortality","volume":"40","author":"Hojyo","year":"2020","journal-title":"Inflamm Regen"},{"issue":"3","key":"10.1016\/j.ajmo.2024.100068_bib0164","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/infdis\/jiab044","article-title":"Monocytes and macrophages, targets of severe acute respiratory syndrome coronavirus 2: the clue for coronavirus disease 2019 immunoparalysis","volume":"224","author":"Boumaza","year":"2021","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0165","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1182\/bloodadvances.2021005949","article-title":"Inflammasome activation in neutrophils of patients with severe COVID-19","volume":"6","author":"Aymonnier","year":"2022","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.ajmo.2024.100068_bib0166","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.4049\/jimmunol.139.6.1902","article-title":"Interleukin 1 induces interleukin 1. I: induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro","volume":"139","author":"Dinarello","year":"1987","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ajmo.2024.100068_bib0167","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.4049\/jimmunol.139.6.1911","article-title":"Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells","volume":"139","author":"Warner","year":"1987","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0168","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4049\/jimmunol.142.1.100","article-title":"Human vascular smooth muscle cells. Target for and source of tumor necrosis factor","volume":"142","author":"Warner","year":"1989","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0169","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0008-8749(89)90095-6","article-title":"Adult human vascular endothelial cells express the IL6 gene differentially in response to LPS or IL1","volume":"122","author":"Loppnow","year":"1989","journal-title":"Cell Immunol"},{"issue":"10229","key":"10.1016\/j.ajmo.2024.100068_bib0170","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ajmo.2024.100068_bib0171","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/10408363.2020.1770685","article-title":"Biomarkers associated with COVID-19 disease progression","volume":"57","author":"Ponti","year":"2020","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"14","key":"10.1016\/j.ajmo.2024.100068_bib0172","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/cvr\/cvaa230","article-title":"Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC council of basic cardiovascular science","volume":"116","author":"Evans","year":"2020","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0173","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/v13010029","article-title":"Endothelium infection and dysregulation by SARS-CoV-2: evidence and caveats in COVID-19","volume":"13","author":"Bernard","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ajmo.2024.100068_bib0174","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8671713","article-title":"Endothelial dysfunction, inflammation, and oxidative stress in COVID-19-mechanisms and therapeutic targets","volume":"2021","author":"Fodor","year":"2021","journal-title":"Oxid Med Cell Longev"},{"issue":"32","key":"10.1016\/j.ajmo.2024.100068_bib0175","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/eurheartj\/ehaa623","article-title":"COVID-19 is, in the end, an endothelial disease","volume":"41","author":"Libby","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tcm.2020.10.005","article-title":"COVID-19: a vascular disease","volume":"31","author":"Siddiqi","year":"2020","journal-title":"Trends Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.ajmo.2024.100068_bib0177","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00377-2021","article-title":"Between inflammation and thrombosis - endothelial cells in COVID-19","volume":"58","author":"Birnhuber","year":"2021","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0178","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3233\/CH-209007","article-title":"COVID-19 and the endothelium","volume":"75","author":"Jung","year":"2020","journal-title":"Clin Hemorheol Microcirc"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0179","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0180","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1165\/rcmb.2011-0392TR","article-title":"Role of chemokines in the pathogenesis of acute lung injury","volume":"46","author":"Bhatia","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.ajmo.2024.100068_bib0181","doi-asserted-by":"crossref","unstructured":"Liu Q., et al. Gross examination report of a COVID-19 death autopsy. 2020;36(1):21\u201323. 10.12116\/j.issn.1004-5619.2020.01.005","DOI":"10.51441\/BioMedica\/\/BioMedica\/5-373"},{"issue":"10235","key":"10.1016\/j.ajmo.2024.100068_bib0182","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(20)30920-X","article-title":"SARS-CoV-2 and viral sepsis: observations and hypotheses","volume":"395","author":"Li","year":"2020","journal-title":"Lancet"},{"issue":"10234","key":"10.1016\/j.ajmo.2024.100068_bib0183","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"The Lancet"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0184","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"18","key":"10.1016\/j.ajmo.2024.100068_bib0185","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","article-title":"Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic","volume":"75","author":"Driggin","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.ajmo.2024.100068_bib0186","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.120.046941","article-title":"COVID-19 and cardiovascular disease","volume":"141","author":"Clerkin","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0187","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"19","key":"10.1016\/j.ajmo.2024.100068_bib0188","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/eurheartj\/ehaa231","article-title":"Coronaviruses and the cardiovascular system: acute and long-term implications","volume":"41","author":"Xiong","year":"2020","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0189","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0190","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","article-title":"Kidney disease is associated with in-hospital death of patients with COVID-19","volume":"97","author":"Cheng","year":"2020","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0191","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.kint.2020.05.006","article-title":"Acute kidney injury in patients hospitalized with COVID-19","volume":"98","author":"Hirsch","year":"2020","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0192","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1038\/s41380-022-01831-0","article-title":"SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein","volume":"28","author":"Albornoz","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"3","key":"10.1016\/j.ajmo.2024.100068_bib0193","first-page":"138","article-title":"NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes","volume":"14","author":"Dutta","year":"2022","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"10.1016\/j.ajmo.2024.100068_bib0194","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/925135","article-title":"CD4+T cells: differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0195","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0196","article-title":"Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases","volume":"2","author":"Tarke","year":"2021","journal-title":"Cell Rep Med"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0197","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41423-020-00588-2","article-title":"A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity","volume":"18","author":"Legros","year":"2021","journal-title":"Cell Mol Immunol."},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0198","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262169","article-title":"SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection","volume":"17","author":"Havervall","year":"2022","journal-title":"PLOS ONE"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0199","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology","volume":"183","author":"Piccoli","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ajmo.2024.100068_bib0200","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijid.2021.08.026","article-title":"Cross-reactive humoral immune responses against seasonal human coronaviruses in COVID-19 patients with different disease severities","volume":"111","author":"Imai","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ajmo.2024.100068_bib0201","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.708184","article-title":"Dynamic characteristic analysis of antibodies in patients with COVID-19: a 13-month study","volume":"12","author":"Shi","year":"2021","journal-title":"Front Immunol"},{"issue":"7851","key":"10.1016\/j.ajmo.2024.100068_bib0202","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","article-title":"Evolution of antibody immunity to SARS-CoV-2","volume":"591","author":"Gaebler","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ajmo.2024.100068_bib0203","article-title":"Rapid generation of neutralizing antibody responses in COVID-19 patients","volume":"1","author":"Suthar","year":"2020","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ajmo.2024.100068_bib0204","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.655896","article-title":"IgA antibodies and IgA deficiency in SARS-CoV-2 infection","volume":"11","author":"Quinti","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0205","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41577-020-0359-5","article-title":"Dissecting antibody-mediated protection against SARS-CoV-2","volume":"20","author":"Zohar","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"49","key":"10.1016\/j.ajmo.2024.100068_bib0206","doi-asserted-by":"crossref","first-page":"eabd7114","DOI":"10.1126\/sciimmunol.abd7114","article-title":"Comprehensive mapping of immune perturbations associated with severe COVID-19","volume":"5","author":"Kuri-Cervantes","year":"2020","journal-title":"Sci Immunol"},{"issue":"9","key":"10.1016\/j.ajmo.2024.100068_bib0207","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1172\/JCI138554","article-title":"Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent","volume":"130","author":"Mazzoni","year":"2020","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.ajmo.2024.100068_bib0208","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41423-020-00557-9","article-title":"Unique immunological profile in patients with COVID-19","volume":"18","author":"Varchetta","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ajmo.2024.100068_bib0209","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0210","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/iid3.526","article-title":"TIM-3 as a potential exhaustion marker in CD4 + T cells of COVID-19 patients","volume":"9","author":"Modabber","year":"2021","journal-title":"Immun Inflamm Dis"},{"issue":"55","key":"10.1016\/j.ajmo.2024.100068_bib0211","doi-asserted-by":"crossref","first-page":"eabe4782","DOI":"10.1126\/sciimmunol.abe4782","article-title":"Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8 + T cells","volume":"6","author":"Kusnadi","year":"2021","journal-title":"Sci Immunol"},{"issue":"9","key":"10.1016\/j.ajmo.2024.100068_bib0212","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1111\/all.14866","article-title":"Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19","volume":"76","author":"Adamo","year":"2021","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0213","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"10.1016\/j.ajmo.2024.100068_bib0214","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109518","article-title":"Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms","volume":"36","author":"Peluso","year":"2021","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0215","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202515","article-title":"Persistent cellular immunity to SARS-CoV-2 infection","volume":"218","author":"Breton","year":"2021","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.ajmo.2024.100068_bib0216","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jama.2020.27124","article-title":"Genetic variants of SARS-CoV-2\u2014what do they mean?","volume":"325","author":"Lauring","year":"2021","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.ajmo.2024.100068_bib0217","doi-asserted-by":"crossref","first-page":"eabb5813","DOI":"10.1126\/sciadv.abb5813","article-title":"Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2","volume":"6","author":"Di Giorgio","year":"2020","journal-title":"Sci Adv"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0218","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.tibs.2016.05.001","article-title":"The APOBEC protein family: united by structure, divergent in function","volume":"41","author":"Salter","year":"2016","journal-title":"Trends Biochem Sci"},{"issue":"9","key":"10.1016\/j.ajmo.2024.100068_bib0219","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1101\/gr.2855504","article-title":"Widespread RNA editing of embedded Alu elements in the human transcriptome","volume":"14","author":"Kim","year":"2004","journal-title":"Genome Res"},{"key":"10.1016\/j.ajmo.2024.100068_bib0220","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbrc.2020.10.092","article-title":"Host-directed editing of the SARS-CoV-2 genome","volume":"538","author":"Mourier","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajmo.2024.100068_bib0221","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.809244","article-title":"SARS-CoV-2 variants, vaccines, and host immunity","volume":"12","author":"Mistry","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajmo.2024.100068_bib0222","unstructured":"World Health Organization. COVID-19 weekly epidemiological update. Special edition: proposed working definitions of SARS-CoV-2 variants of interest and variants of concern. Available at: Https:\/\/Www.Who.Int\/Publications\/m\/Item\/Covid-19-Weekly-Epidemiological-Update."},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0223","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"issue":"13","key":"10.1016\/j.ajmo.2024.100068_bib0224","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jama.2021.3199","article-title":"SARS-CoV-2 vaccines","volume":"325","author":"Creech","year":"2021","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ajmo.2024.100068_bib0226","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3349\/ymj.2021.62.11.961","article-title":"SARS-CoV-2 variants of concern","volume":"62","author":"Choi","year":"2021","journal-title":"Yonsei Med J"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0227","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041390","article-title":"The evolution and biology of SARS-CoV-2 variants","volume":"12","author":"Telenti","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"12","key":"10.1016\/j.ajmo.2024.100068_bib0228","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41576-021-00408-x","article-title":"The biological and clinical significance of emerging SARS-CoV-2 variants","volume":"22","author":"Tao","year":"2021","journal-title":"Nat Rev Genet"},{"issue":"11","key":"10.1016\/j.ajmo.2024.100068_bib0225","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41564-020-0770-5","article-title":"A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology","volume":"5","author":"Rambaut","year":"2020","journal-title":"Nat Microbiol"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0229","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1196\/annals.1422.059","article-title":"Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report","volume":"1108","author":"Barzilai","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0230","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12016-007-8013-6","article-title":"Hepatitis B virus (HBV) and autoimmune disease","volume":"34","author":"Maya","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"10.1016\/j.ajmo.2024.100068_bib0231","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1006\/clin.1995.1154","article-title":"IgG autoantibody response in HTLV-I-infected patients","volume":"77","author":"Muller","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"issue":"9","key":"10.1016\/j.ajmo.2024.100068_bib0232","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00002030-199209000-00004","article-title":"Autoantibodies typical of non-organ-specific autoimmune diseases in HIV-seropositive patients","volume":"6","author":"Muller","year":"1992","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.ajmo.2024.100068_bib0233","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1172\/JCI200112173","article-title":"T cell homeostasis and systemic autoimmunity","volume":"108","author":"Theofilopoulos","year":"2001","journal-title":"J Clin Invest"},{"issue":"15","key":"10.1016\/j.ajmo.2024.100068_bib0234","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0235","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.19.1.80-94.2006","article-title":"Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease","volume":"19","author":"Fujinami","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"10.1016\/j.ajmo.2024.100068_bib0236","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102597","article-title":"Covid-19 and autoimmunity","volume":"19","author":"Ehrenfeld","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0237","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102792","article-title":"The SARS-CoV-2 as an instrumental trigger of autoimmunity","volume":"20","author":"Dotan","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.ajmo.2024.100068_bib0238","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3389\/fphar.2020.00870","article-title":"Neutrophilia and NETopathy as key pathologic drivers of progressive lung impairment in patients with COVID-19","volume":"11","author":"Narasaraju","year":"2020","journal-title":"Front Pharmacol"},{"issue":"8","key":"10.1016\/j.ajmo.2024.100068_bib0239","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41584-018-0039-z","article-title":"The role of neutrophil extracellular traps in rheumatic diseases","volume":"14","author":"Apel","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"10.1016\/j.ajmo.2024.100068_bib0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102865","article-title":"Autoimmunity and COVID-19: the microbiotal connection","volume":"20","author":"Katz-Agranov","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0241","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/jir.2019.0011","article-title":"Mechanisms by which the gut microbiota influences cytokine production and modulates host inflammatory responses","volume":"39","author":"Mendes","year":"2019","journal-title":"J Interferon Cytokine Res"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0242","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.coi.2011.07.010","article-title":"Pathobionts of the gastrointestinal microbiota and inflammatory disease","volume":"23","author":"Chow","year":"2011","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0243","first-page":"276","article-title":"Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19","volume":"70","author":"Zuo","year":"2020","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0244","first-page":"74","article-title":"The microbiome in autoimmune diseases","volume":"195","author":"Whiteside","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ajmo.2024.100068_bib0245","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.705020","article-title":"Gut microbiota diversity and c-reactive protein are predictors of disease severity in COVID-19 patients","volume":"12","author":"Moreira-Ros\u00e1rio","year":"2021","journal-title":"Front Microbiol"},{"issue":"9","key":"10.1016\/j.ajmo.2024.100068_bib0246","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3390\/pathogens11091050","article-title":"Gut microbiota and COVID-19: potential implications for disease severity","volume":"11","author":"Rocchi","year":"2022","journal-title":"Pathogens"},{"issue":"25","key":"10.1016\/j.ajmo.2024.100068_bib0247","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.3748\/wjg.v28.i25.2802","article-title":"Altered gut microbiota patterns in COVID-19: markers for inflammation and disease severity","volume":"28","author":"Chakraborty","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0248","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12967-022-03328-4","article-title":"Autoimmunity is a hallmark of post-COVID syndrome","volume":"20","author":"Rojas","year":"2022","journal-title":"J Transl Med"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0249","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/cts.12908","article-title":"COVID-19 and immunological dysregulation: can autoantibodies be useful?","volume":"14","author":"Pascolini","year":"2020","journal-title":"Clin Transl Sci"},{"issue":"9","key":"10.1016\/j.ajmo.2024.100068_bib0250","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/annrheumdis-2021-220206","article-title":"Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients","volume":"80","author":"Trahtemberg","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0251","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001580","article-title":"Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review","volume":"7","author":"Taha","year":"2021","journal-title":"RMD Open"},{"key":"10.1016\/j.ajmo.2024.100068_bib0252","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.thromres.2020.05.017","article-title":"Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism","volume":"192","author":"Galeano-Valle","year":"2020","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0253","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ajmo.2024.100068_bib0254","article-title":"Long-term evaluation of antiphospholipid antibodies in patients with COVID-19","author":"Ghilardi","year":"2021","journal-title":"Preprints with The Lancet."},{"key":"10.1016\/j.ajmo.2024.100068_bib0255","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/01.HS9.0000849344.70911.19","article-title":"P1622: antiphospholipid antibodies in convalescent plasma of donors recovered from mild COVID-19","volume":"6","author":"Blickstein","year":"2022","journal-title":"HemaSphere"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0256","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1053\/sarh.2002.28303","article-title":"Viral infections and antiphospholipid antibodies","volume":"31","author":"Uthman","year":"2002","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0257","first-page":"1","volume":"6","author":"Almashat","year":"2020","journal-title":"Vasculitis in COVID-19: a literature review"},{"issue":"9","key":"10.1016\/j.ajmo.2024.100068_bib0258","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074529","article-title":"Seasonality of Kawasaki disease: a global perspective","volume":"8","author":"Burns","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0259","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/01.ede.0000152901.06689.d4","article-title":"Seasonality and temporal clustering of Kawasaki syndrome","volume":"16","author":"Burns","year":"2005","journal-title":"Epidemiology"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0260","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2188\/jea.JE20110131","article-title":"Epidemiology of Kawasaki disease in Asia, Europe, and the United States","volume":"22","author":"Uehara","year":"2012","journal-title":"J Epidemiol"},{"key":"10.1016\/j.ajmo.2024.100068_bib0261","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110117","article-title":"Kawasaki-like disease in children with COVID-19: a hypothesis","volume":"143","author":"Amirfakhryan","year":"2020","journal-title":"Med Hypotheses"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0262","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1186\/s12864-015-2323-5","article-title":"The transcriptional profile of coronary arteritis in Kawasaki disease","volume":"16","author":"Rowley","year":"2015","journal-title":"BMC Genomics"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0263","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3855\/jidc.14185","article-title":"Kawasaki like illness due to COVID-19: a review of the literature","volume":"15","author":"Fang","year":"2021","journal-title":"J Infect Dev Ctries"},{"issue":"3","key":"10.1016\/j.ajmo.2024.100068_bib0264","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1442-200x.2005.02049.x","article-title":"Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease","volume":"47","author":"Takahashi","year":"2005","journal-title":"Pediatr Int"},{"issue":"12","key":"10.1016\/j.ajmo.2024.100068_bib0265","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/CIRCULATIONAHA.111.072769","article-title":"Interleukin-1\u03b2 is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease","volume":"125","author":"Lee","year":"2012","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.ajmo.2024.100068_bib0266","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1161\/CIRCULATIONAHA.111.028423","article-title":"Ulinastatin, a urinary trypsin inhibitor, for the initial treatment of patients with Kawasaki disease a retrospective study","volume":"124","author":"Kanai","year":"2011","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ajmo.2024.100068_bib0267","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/heartjnl-2019-315925","article-title":"Lifetime cardiovascular management of patients with previous Kawasaki disease","volume":"106","author":"Brogan","year":"2020","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.ajmo.2024.100068_bib0268","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2352-4642(20)30175-9","article-title":"Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis","volume":"4","author":"Ouldali","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"issue":"10239","key":"10.1016\/j.ajmo.2024.100068_bib0269","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study","volume":"395","author":"Verdoni","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0270","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12519-021-00499-w","article-title":"Clinical practice guidelines in multisystem inflammatory syndrome (MIS-C) related to COVID-19: a critical review and recommendations","volume":"18","author":"Algarni","year":"2022","journal-title":"World J Pediatr"},{"issue":"8","key":"10.1016\/j.ajmo.2024.100068_bib0271","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/annrheumdis-2020-218110","article-title":"Kawasaki disease or Kawasaki syndrome","volume":"79","author":"Ravelli","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajmo.2024.100068_bib0272","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.clineuro.2017.05.006","article-title":"Guillain-Barr\u00e9 Syndrome, variants & forms fruste: reclassification with new criteria","volume":"158","author":"Hiew","year":"2017","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0273","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ncl.2013.01.005","article-title":"Guillain-Barr\u00e9 syndrome and variants","volume":"31","author":"Dimachkie","year":"2013","journal-title":"Neurol Clin"},{"issue":"2","key":"10.1016\/j.ajmo.2024.100068_bib0274","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000184748","article-title":"The epidemiology of Guillain-Barre syndrome worldwide a systematic literature review","volume":"32","author":"McGrogan","year":"2009","journal-title":"Neuroepidemiology"},{"issue":"8","key":"10.1016\/j.ajmo.2024.100068_bib0275","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain\u2013Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"22","key":"10.1016\/j.ajmo.2024.100068_bib0276","doi-asserted-by":"crossref","first-page":"14222","DOI":"10.3390\/ijms232214222","article-title":"Triggers of Guillain\u2013Barr\u00e9 syndrome: Campylobacter jejuni predominates","volume":"23","author":"Finsterer","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.ajmo.2024.100068_bib0277","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1089\/vim.2021.0187","article-title":"SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: lessons from viral infections","volume":"35","author":"Meidaninikjeh","year":"2022","journal-title":"Viral Immunol"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0278","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ajmo.2024.100068_bib0279","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/cid\/cit512","article-title":"Hepatitis E and Guillain-Barr\u00e9 syndrome","volume":"57","author":"GeurtsvanKessel","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0280","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12883-021-02334-1","article-title":"Hepatitis E virus as a trigger for Guillain-Barr\u00e9 syndrome","volume":"21","author":"Fritz-Weltin","year":"2021","journal-title":"BMC Neurol"},{"issue":"24","key":"10.1016\/j.ajmo.2024.100068_bib0281","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajmo.2024.100068_bib0282","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3988\/jcn.2017.13.3.227","article-title":"Neurological complications during treatment of middle east respiratory syndrome","volume":"13","author":"Kim","year":"2017","journal-title":"J Clin Neurol"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0283","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1017\/cjn.2021.102","article-title":"Guillain Barre syndrome as a complication of COVID-19: a systematic review","volume":"49","author":"Aladawi","year":"2022","journal-title":"Can J Neurol Sci"},{"issue":"10","key":"10.1016\/j.ajmo.2024.100068_bib0284","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1111\/ene.14860","article-title":"Prevalence, clinical characteristics and outcomes of Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: a systematic review and meta-analysis","volume":"28","author":"Palaiodimou","year":"2021","journal-title":"Eur J Neurol"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0285","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/jnnp-2020-324837","article-title":"Guillain-Barr\u00e9 syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions","volume":"92","author":"Filosto","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"10.1016\/j.ajmo.2024.100068_bib0286","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1007\/s10072-020-04693-y","article-title":"Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports","volume":"41","author":"Rahimi","year":"2020","journal-title":"Neurol Sci"},{"key":"10.1016\/j.ajmo.2024.100068_bib0287","article-title":"Guillain\u2013Barr\u00e9 syndrome associated with COVID-19: a systematic review","volume":"28","author":"Pimentel","year":"2023","journal-title":"Brain Behav Immun Health"},{"issue":"10","key":"10.1016\/j.ajmo.2024.100068_bib0288","first-page":"849","article-title":"Eighty three years of the Guillain-Barr\u00e9 syndrome: clinical and immunopathologic aspects, current and future treatments","volume":"155","author":"Toyka","year":"1999","journal-title":"Rev Neurol (Paris)"},{"issue":"6","key":"10.1016\/j.ajmo.2024.100068_bib0289","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.ajmo.2024.100068_bib0290","first-page":"4","article-title":"Guillain-Barr\u00e9 syndrome after COVID-19 in Japan","volume":"13","author":"Hirayama","year":"2020","journal-title":"Case Rep"},{"key":"10.1016\/j.ajmo.2024.100068_bib0291","unstructured":"Coronavirus (COVID-19) Vaccinations. https:\/\/ourworldindata.org\/covid-vaccinations. Retreived Aug 20, 2023."},{"key":"10.1016\/j.ajmo.2024.100068_bib0292","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijid.2021.11.009","article-title":"Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis","volume":"114","author":"Zheng","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0293","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(21)00460-6","article-title":"Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study","volume":"22","author":"Antonelli","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"32","key":"10.1016\/j.ajmo.2024.100068_bib0294","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.15585\/mmwr.mm7032e4","article-title":"Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna): update from the Advisory Committee on Immunization Practices - United States, July 2021","volume":"70","author":"Rosenblum","year":"2021","journal-title":"Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0295","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/imm.13443","article-title":"New-onset autoimmune phenomena post COVID-19 vaccination","volume":"165","author":"Chen","year":"2022","journal-title":"Immunology"},{"issue":"23","key":"10.1016\/j.ajmo.2024.100068_bib0296","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ajmo.2024.100068_bib0297","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0298","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s41591-021-01408-4","article-title":"First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland","volume":"27","author":"Simpson","year":"2021","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0299","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s10067-022-06149-4","article-title":"Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune\/inflammatory syndrome expand?","volume":"41","author":"Jara","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.ajmo.2024.100068_bib0300","doi-asserted-by":"crossref","first-page":"e678","DOI":"10.1016\/S2665-9913(21)00218-6","article-title":"Adult-onset Still's disease following COVID-19 vaccination","volume":"3","author":"Leone","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ajmo.2024.100068_bib0301","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108878","article-title":"Adult-onset Still's disease following mRNA COVID-19 vaccination","volume":"233","author":"Sharabi","year":"2021","journal-title":"Clin Immunol"},{"issue":"10","key":"10.1016\/j.ajmo.2024.100068_bib0302","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.1016\/S2665-9913(21)00219-8","article-title":"Adult-onset Still's disease after mRNA COVID-19 vaccine","volume":"3","author":"Magliulo","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0303","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s10067-022-06065-7","article-title":"New-onset Adult-onset Still's disease-like syndrome after ChAdOx1 nCoV-19 vaccination: a case series with review of literature","volume":"41","author":"Padiyar","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0304","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00296-021-05052-6","article-title":"A flare of Still's disease following COVID-19 vaccination in a 34-year-old patient","volume":"42","author":"Jeon","year":"2022","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0305","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s10067-022-06124-z","article-title":"Two flares of Still's disease after two doses of the ChAdOx1 vaccine","volume":"41","author":"Roongta","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ajmo.2024.100068_bib0306","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2022.100140","article-title":"COVID-19 vaccine and autoimmunity. A new case of autoimmune hepatitis and review of the literature","volume":"5","author":"Camacho-Dom\u00ednguez","year":"2022","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.ajmo.2024.100068_bib0307","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102154","article-title":"Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study","volume":"63","author":"Peng","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"3","key":"10.1016\/j.ajmo.2024.100068_bib0308","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/vaccines8030554","article-title":"Inflammasome-mediated immunogenicity of clinical and experimental vaccine adjuvants","volume":"8","author":"Reinke","year":"2020","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.ajmo.2024.100068_bib0309","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s10067-020-05180-7","article-title":"High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia","volume":"39","author":"Gazzaruso","year":"2020","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0310","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1111\/cts.13036","article-title":"Autoantibodies in moderate and critical cases of COVID-19","volume":"14","author":"Chang","year":"2021","journal-title":"Clin Transl Sci"},{"issue":"4","key":"10.1016\/j.ajmo.2024.100068_bib0311","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.semarthrit.2020.05.001","article-title":"Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs","volume":"50","author":"Michelena","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.ajmo.2024.100068_bib0312","first-page":"1343","article-title":"Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs","volume":"48","author":"Filocamo","year":"2020","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.ajmo.2024.100068_bib0313","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMc2009567","article-title":"Covid-19 in immune-mediated inflammatory diseases: case series from New York","volume":"383","author":"Haberman","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ajmo.2024.100068_bib0314","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/annrheumdis-2020-217424","article-title":"Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies","volume":"79","author":"Monti","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ajmo.2024.100068_bib0315","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3899\/jrheum.200507","article-title":"Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis","volume":"47","author":"Favalli","year":"2020","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.ajmo.2024.100068_bib0316","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"}],"container-title":["American Journal of Medicine Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667036424000050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667036424000050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T16:06:41Z","timestamp":1718294801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667036424000050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":316,"alternative-id":["S2667036424000050"],"URL":"https:\/\/doi.org\/10.1016\/j.ajmo.2024.100068","relation":{},"ISSN":["2667-0364"],"issn-type":[{"value":"2667-0364","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review","name":"articletitle","label":"Article Title"},{"value":"American Journal of Medicine Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajmo.2024.100068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100068"}}